Blog - Page 3 of 5772 - QualityStocks

FridayOct 30, 2026 10:23 am

QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Gains Industry Relevance as FDA Eases Restrictions on Pharmacy-Compounded Peptides, NBC News Reports

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is drawing attention amid changes to the regulatory environment for peptide-based treatments, as federal health officials move to allow compounding pharmacies to immediately offer six previously restricted peptides without waiting for formal rulemaking. According to an Oct. 28 NBC News report by Berkeley Lovelace Jr., the Department of Health and Human Services is exercising "enforcement discretion," temporarily suspending legal action against qualifying pharmacies that compound BPC-157, epitalon, KPV, MOTS-c, semax and TB-500. The Food and Drug Administration ("FDA") is requiring pharmacies…

FridayOct 30, 2026 10:19 am

QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Sees Regulatory Landscape Shift as Federal Policy Permits Compounding of Six Peptides, Reuters Reports

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) operates in a peptide sector undergoing a significant regulatory shift following the publication of a new federal policy permitting licensed pharmacies and physicians to compound six previously restricted peptides under specified conditions. According to an Oct. 28 Reuters report by Sneha S K, with additional reporting by Kamal Choudhury and Siddhi Mahatole, the policy, published in the Federal Register, allows compounding of BPC-157, TB-500, epitalon, KPV, MOTS-c and Semax without Food and Drug Administration ("FDA") enforcement action, provided compounders meet requirements…

FridayOct 30, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events

The company demonstrated its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console at two international medical conferences in October 2026. At the European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, CEO Dr. Sudhir Srivastava performed a robotic-assisted atrial septal defect procedure on a patient approximately 7,500 miles away in Bengaluru, India. Four additional robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures. The company reported 205 telesurgeries performed with the SSi Mantra system as of October 23, 2026, including cardiac procedures. The demonstrations highlight…

FridayOct 30, 2026 9:10 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in NetworkNewsAudio Release on AI Chip Inspection and Automation Equipment

Nightfood Holdings (OTCQB: NGTF) is featured in a NetworkNewsAudio Audio Press Release ("APR") titled "Inspection, Automation Equipment Could Be Overlooked Winners of the AI Buildout." The audio release examines growing demand for advanced semiconductor inspection and automation equipment as artificial intelligence ("AI") and high-performance computing drive increasingly complex chip packaging requirements. The editorial highlights industry participants KLA and Onto Innovation, whose inspection technologies address defect detection and quality control in advanced semiconductor manufacturing. The editorial also examines Nightfood Holdings' newly acquired technology, which includes designs and technical know-how for automated optical inspection machines used in chip-on-wafer-on-substrate ("CoWoS") advanced packaging. The…

FridayOct 30, 2026 9:00 am

Silynxcom Ltd. (NYSE American: SYNX) Develops AI-Powered Wearable Drone Detection System as It Expands Into Counter-Drone Defense

The AI-powered wearable acoustic drone-detection and early-warning platform is aimed at protecting individual soldiers from unmanned aircraft threats. The prototype is designed to passively identify drone acoustic signatures rather than relying on radio-frequency emissions, potentially addressing threats from fiber-optic-guided drones that do not transmit conventional radio signals. A mesh-networking capability under development is intended to allow alerts from one device to be shared with other connected users, extending warnings across a platoon. The company plans to develop the technology as a standalone product platform, creating a potential business line beyond its established tactical communication and hearing-protection systems. Silynxcom is entering…

ThursdayOct 29, 2026 3:51 pm

QualityStocksNewsBreaks – American Fusion Inc. (AMFN) Positions Texatron(TM) Development Around Race to Power AI

American Fusion (OTC: AMFN) is advancing testing of its Texatron(TM) Fusion Engine(TM) as it explores opportunities to supply electricity to AI data centers and other power-intensive customers. In a recent AGORACOM interview, Executive Chairman Brent Nelson discussed the company’s 500-kW and 5-MW pre-production systems, plans for larger 10-MW and 20-MW configurations, and a development roadmap covering 12 authorized model classes ranging from approximately 500 kW to 1 GW. The company is targeting documented test results demonstrating energy generation and capture, with a goal of reaching unity or beyond unity by the end of 2026. American Fusion is also exploring a…

ThursdayOct 29, 2026 3:29 pm

QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Spotlights Drinkfinger Expansion, AI Strategy in Stock2Me Podcast

Versus Systems (NASDAQ: VS) is expanding its audience-engagement offerings through Drinkfinger, a QR-enabled beverage carrier that connects live-event attendees with mobile games, rewards and branded content. In a recent IBN Stock2Me Podcast appearance, CEO Luis Goldner and other members of the leadership team discussed plans to target Latin American markets, including Brazil and Mexico, where sporting events, concerts and festivals offer potential opportunities for interactive promotions. The initiative complements Versus’ existing Winfinite platform, which provides customizable web-based games for marketing campaigns, and Filter Fan Cam, which uses augmented-reality effects to enhance live-event experiences and create sponsorship opportunities. Management also discussed…

ThursdayOct 29, 2026 2:48 pm

QualityStocksNewsBreaks – SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) Eyes Super Edge(TM) Success in Military Exercise

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements. SuperQ Quantum (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) was featured in a recent article discussing the performance of its Super Edge(TM) tactical optimization platform, which met 100% of evaluation benchmarks during a live U.S. military exercise at the Bush Combat Development Complex in Texas. The exercise tested the platform’s ability to support real-time logistics optimization, tactical routing, communications resilience and integration with existing military systems under simulated operational conditions. According to the company, Super Edge maintained routing performance during simulated network degradation and bandwidth constraints, without latency…

ThursdayOct 29, 2026 2:17 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Highlights Potential of GelrinC Cartilage Repair Technology

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed the company’s efforts to advance its regenerative cartilage repair technology, GelrinC, as orthopedic medicine increasingly emphasizes durable, long-term treatment outcomes. The company’s lead product is a cell-free, off-the-shelf degradable hydrogel implant designed to support the regeneration of knee cartilage, gradually resorbing over approximately six to nine months as new tissue fills the treated area. Regentis reports that its Pilot/Phase II study showed 100% greater pain improvement compared with traditional microfracture treatment, while 24-month follow-up results showed a mean MOCART score of 88.8 out of 100, an MRI-based measure…

ThursdayOct 29, 2026 10:30 am

Oncotelic Advances PLA from Published Liver Cancer Findings Toward 100 Billion Protein Vectors

PLA gives overlooked biological evidence its own analysis before combining the findings. Published HCC research connects PLA-guided investigation with a four-gene survival signature validated in an independent patient cohort. As Anthropic and OpenAI expand biological discovery with AI agents, Oncotelic is targeting a 100-billion-vector protein program. Oncotelic Therapeutics Inc. (OTCQB: OTLC) is building its PDAOAI drug discovery engine around a compelling premise: a clue buried in a small corner of the literature can redirect an entire research program. Its Partitioned Literature Aggregation (“PLA”) algorithm is designed to uncover those clues. A liver-cancer study published in Biomedicines on October 23, 2026,…

Site Search

Company Search